InvestorsHub Logo

nidan7500

11/13/23 5:44 PM

#438773 RE: falconer66a #438772

Using the new biomarker analysis device wouldn’t it be interesting to see the data from a clinical Alzheimer’s trial comparing blarcamesine with Aricept, Aduhelm, Leqembi, or any of the others so wonderfully approved for clinical use.

by falconer66a...

Back in the day, we would have used the Old Navy expression of..."kicking ass and taking names".